These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
251 related items for PubMed ID: 17707808
21. Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent--a pilot study. Lin KJ, Hsu WC, Hsiao IT, Wey SP, Jin LW, Skovronsky D, Wai YY, Chang HP, Lo CW, Yao CH, Yen TC, Kung MP. Nucl Med Biol; 2010 May; 37(4):497-508. PubMed ID: 20447562 [Abstract] [Full Text] [Related]
22. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease. Toyama H, Ye D, Ichise M, Liow JS, Cai L, Jacobowitz D, Musachio JL, Hong J, Crescenzo M, Tipre D, Lu JQ, Zoghbi S, Vines DC, Seidel J, Katada K, Green MV, Pike VW, Cohen RM, Innis RB. Eur J Nucl Med Mol Imaging; 2005 May; 32(5):593-600. PubMed ID: 15791432 [Abstract] [Full Text] [Related]
23. Initial Evaluation of an Adenosine A2A Receptor Ligand, 11C-Preladenant, in Healthy Human Subjects. Sakata M, Ishibashi K, Imai M, Wagatsuma K, Ishii K, Zhou X, de Vries EFJ, Elsinga PH, Ishiwata K, Toyohara J. J Nucl Med; 2017 Sep; 58(9):1464-1470. PubMed ID: 28280214 [Abstract] [Full Text] [Related]
24. Whole-body biodistribution and estimation of radiation-absorbed doses of the dopamine D1 receptor radioligand 11C-NNC 112 in humans. Cropley VL, Fujita M, Musachio JL, Hong J, Ghose S, Sangare J, Nathan PJ, Pike VW, Innis RB. J Nucl Med; 2006 Jan; 47(1):100-4. PubMed ID: 16391193 [Abstract] [Full Text] [Related]
25. Biodistribution and radiation dosimetry of the amyloid imaging agent 11C-PIB in humans. Scheinin NM, Tolvanen TK, Wilson IA, Arponen EM, Någren KA, Rinne JO. J Nucl Med; 2007 Jan; 48(1):128-33. PubMed ID: 17204709 [Abstract] [Full Text] [Related]
26. Human Radiation Dosimetry for the N-Methyl-D-Aspartate Receptor Radioligand 11C-CNS5161. Dhawan V, Robeson W, Bjelke D, Chaly T, Graf K, Hellman M, Zhuo L, Mackay M, Eidelberg D. J Nucl Med; 2015 Jun; 56(6):869-72. PubMed ID: 25931480 [Abstract] [Full Text] [Related]
27. Whole-body radiation dosimetry of 11C-carbonyl-URB694: a PET tracer for fatty acid amide hydrolase. Boileau I, Bloomfield PM, Rusjan P, Mizrahi R, Mufti A, Vitcu I, Kish SJ, Houle S, Wilson AA, Tong J. J Nucl Med; 2014 Dec; 55(12):1993-7. PubMed ID: 25413137 [Abstract] [Full Text] [Related]
28. Whole-body biodistribution, radiation dosimetry estimates for the PET norepinephrine transporter probe (S,S)-[18F]FMeNER-D2 in non-human primates. Seneca N, Andree B, Sjoholm N, Schou M, Pauli S, Mozley PD, Stubbs JB, Liow JS, Sovago J, Gulyás B, Innis R, Halldin C. Nucl Med Commun; 2005 Aug; 26(8):695-700. PubMed ID: 16000987 [Abstract] [Full Text] [Related]
29. Whole-body biodistribution and dosimetry estimates of a novel radiotracer for imaging of serotonin 4 receptors in brain: [¹⁸F]MNI-698. Tavares AA, Caillé F, Barret O, Papin C, Lee H, Morley TJ, Fowles K, Holden D, Seibyl JP, Alagille D, Tamagnan GD. Nucl Med Biol; 2014 Aug; 41(5):432-9. PubMed ID: 24674817 [Abstract] [Full Text] [Related]
30. 18F-FPYBF-2, a new F-18 labelled amyloid imaging PET tracer: biodistribution and radiation dosimetry assessment of first-in-man 18F-FPYBF-2 PET imaging. Nishii R, Higashi T, Kagawa S, Okuyama C, Kishibe Y, Takahashi M, Okina T, Suzuki N, Hasegawa H, Nagahama Y, Ishizu K, Oishi N, Kimura H, Watanabe H, Ono M, Saji H, Yamauchi H. Ann Nucl Med; 2018 May; 32(4):256-263. PubMed ID: 29453681 [Abstract] [Full Text] [Related]
31. 18F-labeled styrylpyridines as PET agents for amyloid plaque imaging. Zhang W, Kung MP, Oya S, Hou C, Kung HF. Nucl Med Biol; 2007 Jan; 34(1):89-97. PubMed ID: 17210465 [Abstract] [Full Text] [Related]
32. Whole-body biodistribution and radiation dosimetry estimates for the PET dopamine transporter probe 18F-FECNT in non-human primates. Tipre DN, Fujita M, Chin FT, Seneca N, Vines D, Liow JS, Pike VW, Innis RB. Nucl Med Commun; 2004 Jul; 25(7):737-42. PubMed ID: 15208503 [Abstract] [Full Text] [Related]
33. Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptors. Imaizumi M, Briard E, Zoghbi SS, Gourley JP, Hong J, Fujimura Y, Pike VW, Innis RB, Fujita M. Neuroimage; 2008 Feb 01; 39(3):1289-98. PubMed ID: 18024084 [Abstract] [Full Text] [Related]
36. Characterization of [11C]PXT012253 as a PET Radioligand for mGlu4 Allosteric Modulators in Nonhuman Primates. Takano A, Nag S, Jia Z, Jahan M, Forsberg A, Arakawa R, Grybäck P, Duvey G, Halldin C, Charvin D. Mol Imaging Biol; 2019 Jun 01; 21(3):500-508. PubMed ID: 30066121 [Abstract] [Full Text] [Related]
38. PET imaging evaluation of [(18)F]DBT-10, a novel radioligand specific to α7 nicotinic acetylcholine receptors, in nonhuman primates. Hillmer AT, Zheng MQ, Li S, Scheunemann M, Lin SF, Holden D, Labaree D, Ropchan J, Teodoro R, Deuther-Conrad W, Carson RE, Brust P, Huang Y. Eur J Nucl Med Mol Imaging; 2016 Mar 01; 43(3):537-47. PubMed ID: 26455500 [Abstract] [Full Text] [Related]
39. Whole-body distribution and radiation dosimetry of the dopamine transporter radioligand [(11)C]PE2I in healthy volunteers. Ribeiro MJ, Ricard M, Lièvre MA, Bourgeois S, Emond P, Gervais P, Dollé F, Syrota A. Nucl Med Biol; 2007 May 01; 34(4):465-70. PubMed ID: 17499737 [Abstract] [Full Text] [Related]
40. Radiation dosimetry and biodistribution in monkey and man of 11C-PBR28: a PET radioligand to image inflammation. Brown AK, Fujita M, Fujimura Y, Liow JS, Stabin M, Ryu YH, Imaizumi M, Hong J, Pike VW, Innis RB. J Nucl Med; 2007 Dec 01; 48(12):2072-9. PubMed ID: 18006619 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]